PROBLEM TO BE SOLVED: To provide a rotigotine-containing percutaneous absorption type patch formulation which suppresses precipitation of the crystal component derived from rotigotine, and can suppress decreased feeling of use, reduction of skin adhesion or the like.SOLUTION: In a percutaneous absorption type patch formulation consisting of a base material, a drug-containing layer, and a release liner, the drug containing layer contains a rubber pressure sensitive adhesive which contains rosin resin and a rubber adhesive component as a base component, and rotigotine or a pharmaceutically acceptable salt thereof as an active ingredient.COPYRIGHT: (C)2014,JPO&INPIT【課題】ロチゴチン由来の結晶成分の析出を抑制し、使用感の低下、皮膚接着力の減少等を抑制できるロチゴチン含有経皮吸収型貼付製剤の提供。【解決手段】支持体、薬物含有層および剥離ライナーからなる経皮吸収型貼付製剤において、該薬物含有層が、基剤成分としてロジン系樹脂とゴム系粘着成分とを含有するゴム系粘着剤と、有効成分としてロチゴチンまたはその製薬上許容できる塩とを含有してなる経皮吸収型貼付製剤。【選択図】なし
